What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2024-08-14 compared with 2024-05-15 · 17 added, 23 removed, 13 unchanged (75% of the section changed)

Exclusive Option and Asset Purchase Agreement, by and between Enteris Biopharma, Inc., SWK Holdings Corporation and AptarGroup, Inc., dated March 13, 2024.

Consulting Agreement, by and between SWK Holdings Corporation and Yvette Heinrichson, dated February 14, 2024.**

Third Amended and Restated Certificate of Incorporation, dated as of August 12, 2022.

Amended and Restated Bylaws, dated as of August 12, 2022.

Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certification of Principal Executive Officer pursuant to 18 U.S.C.

Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

Certification of Principal Financial Officer pursuant to 18 U.S.C.

Section 1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*

Taxonomy Extension Schema

3 unchanged sentences

Taxonomy Extension Presentation

certifications accompany this Quarterly Report on Form 10-Q.

They are not deemed “filed”

with the Securities and Exchange Commission and are not to be incorporated by reference in

any filing of SWK Holdings Corporation under the Securities Act of 1933, as amended, or the

Securities Exchange Act of 1934, as amended, whether made before or after the date hereof

and irrespective of any general incorporation language in any filings.

** Management

contracts and compensatory plans and arrangements required to be filed as exhibits pursuant

to Item 15(b) of this report.

* These certifications accompany

this Quarterly Report on Form 10-Q.

They are not deemed “filed” with the Securities and Exchange Commission and are not to

be incorporated by reference in any filing of SWK Holdings Corporation under the Securities Act of 1933, as amended, or the Securities

Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language

in any filings.

information is furnished and not filed or a part of a registration statement or prospectus

2 unchanged sentences

otherwise is not subject to liability under these sections.

portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation

The registrant agrees to furnish supplementally an unredacted copy of the exhibit to

the SEC upon request.

and/or schedules to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation

The registrant agrees to furnish supplementally copies of any omitted exhibits or schedules

to the SEC upon request;

provided, however, that the registrant may request confidential

treatment pursuant to Rule 24b-2 of the Exchange Act for any exhibits or schedules so furnished.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report

to be signed on its behalf by the undersigned, thereunto duly authorized, on May 15, 2024.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to

be signed on its behalf by the undersigned, thereunto duly authorized, on August 14, 2024.

Holdings Corporation

Executive Officer

Executive Officer, Principal Financial and Accounting Officer)

Executive Officer)

Financial Officer

Financial and Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information